Cetuximab
CRCST-L0002
Phase 2 small_molecule completed
Quick answer
Cetuximab for Head and Neck Neoplasm is a Phase 2 program (small_molecule) at Solid Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Solid Biosciences
- Indication
- Head and Neck Neoplasm
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed